Signaling via the Interleukin-10 Receptor Attenuates Cardiac Hypertrophy in Mice During Pressure Overload, but not Isoproterenol Infusion
Inflammation plays a key role during cardiac hypertrophy and the development of heart failure. Interleukin-10 (IL-10) is a major anti-inflammatory cytokine that is expressed in the heart and may play a crucial role in cardiac remodeling. Based on the evidence that IL-10 potentially reduces pathologi...
Main Authors: | Nicholas Stafford, Farryah Assrafally, Sukhpal Prehar, Min Zi, Ana M. De Morais, Arfa Maqsood, Elizabeth J. Cartwright, Werner Mueller, Delvac Oceandy |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.559220/full |
Similar Items
-
Cardiac hypertrophy or failure? - A systematic evaluation of the transverse aortic constriction model in C57BL/6NTac and C57BL/6J substrains
by: Min Zi, et al.
Published: (2019-12-01) -
The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy
by: Tamer M. A. Mohamed, et al.
Published: (2016-03-01) -
PMCA4 inhibition does not affect cardiac remodelling following myocardial infarction, but may reduce susceptibility to arrhythmia
by: Nicholas Stafford, et al.
Published: (2021-01-01) -
Treatment with αvβ3-integrin-specific 29P attenuates pressure-overload induced cardiac remodelling after transverse aortic constriction in mice
by: Alexandra Njegić, et al.
Published: (2024-06-01) -
Genetic and Pharmacological YAP Activation Induces Proliferation and Improves Survival in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Thuy Anh Bui, et al.
Published: (2023-08-01)